Asset Details
Do you wish to reserve the book?
Chitosan mitigates pan drug resistance in citrobacter freundii exhibiting AmpC and ESBL from Egyptian livestock
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chitosan mitigates pan drug resistance in citrobacter freundii exhibiting AmpC and ESBL from Egyptian livestock
Do you wish to request the book?
Chitosan mitigates pan drug resistance in citrobacter freundii exhibiting AmpC and ESBL from Egyptian livestock
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Chitosan mitigates pan drug resistance in citrobacter freundii exhibiting AmpC and ESBL from Egyptian livestock
2025
Overview
Extended-spectrum beta-lactamase (ESBL) and ampicillin resistance gene type C (ampC) in foodborne Citrobacter freundii (C. freundii) pose a severe public health risk, especially when they combine with other critical resistance genes to produce a reservoir of resistance. Therefore, the current study aimed to estimate the prevalence, phenotypic, and genotypic profiling of antimicrobial resistance in C. freundii isolates obtained from diseased broiler chickens and native Egyptian buffaloes in Kafr El-Sheikh and Dakahlia governorates, Egypt. Also, the investigation of the antibacterial activity of chitosan (CS) 1%, 2%, and chitosan nanoparticles (CSNPs), including the estimation of minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) and their combinations with ciprofloxacin (CIP), were evaluated. C. freundii was detected in 57.58% (19/33) of broiler chickens and 52.63% (20/38) of buffalo. Surprisingly, 26.32% (5/19) and 20% (4/20) of chicken and buffalo samples, respectively were multidrug-resistant (MDR), 42.11% (8/19) and 15% (3/20) were extensively drug-resistant (XDR), and 31.58% (6/19) and 65% (13/20) were pan drug-like-resistant (PDR). High frequencies of resistance genes were observed, including int1, dfrA1, sul2, aadA1, qnrA, and bla
(≥ 80%), while other genes such as ermB, bla
, bla
, tet(M), mcr-1, bla
and catA1 were detected at variable rates. Alarmingly, all ESBL/AmpC-producing isolates co-harbored multiple critical resistance genes. CSNPs showed markedly lower MIC and MBC values compared with 1% and 2% CS, indicating significantly stronger bactericidal activity. The concerning prevalence of PDR like-C. freundii in food animals is brought to light by our results, which also provide credence to the use of 2% CS-CIP and CSNPs-CIP combinations as potential substitute treatments for resistant infections.
Publisher
Nature Publishing Group,Nature Portfolio
Subject
/ Animals
/ Anti-Bacterial Agents - pharmacology
/ Antimicrobial resistance profiling
/ Bacterial Proteins - genetics
/ Bacterial Proteins - metabolism
/ beta-Lactamases - metabolism
/ Buffalo
/ Chickens
/ Chitosan
/ Ciprofloxacin - pharmacology
/ Citrobacter freundii - drug effects
/ Citrobacter freundii - genetics
/ Citrobacter freundii - isolation & purification
/ Diarrhea
/ Disease
/ Drug Resistance, Multiple, Bacterial - drug effects
/ Drug Resistance, Multiple, Bacterial - genetics
/ Egypt
/ Enterobacteriaceae Infections - drug therapy
/ Enterobacteriaceae Infections - microbiology
/ Enterobacteriaceae Infections - veterinary
/ Feeds
/ Genes
/ Minimum inhibitory concentration
/ Poultry
/ Sepsis
/ Zoonoses
